Cytokinetics (CYTK)
NASDAQ:CYTK
Want to see CYTK full AI Analyst Report?
Cytokinetics (CYTK) Ownership Overview
0.83% Insiders
37.95% Mutual Funds
2.73% Other Institutional Investors
23.64% ETFs
34.85% Public Companies and
Individual Investors
The ownership structure of Cytokinetics (CYTK) stock is a mix of institutional, retail, and individual investors. Approximately 64.32% of the company’s stock is owned by Institutional Investors, 0.83% is owned by Insiders, and 34.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 05, 2026 | xxxxxxxxxxxxx | $302400 | |
May 05, 2026 | xxxxxxxxxxxxx | $1837654 | |
May 05, 2026 | xxxxxxxxxxxxx | $1519400 | |
May 05, 2026 | xxxxxxxxxxxxx | $875474 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $9176828 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $52286113 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $355824 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $24515003 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,120,729 | Institution | 9.03% | 826,158,957 | |
| 10,498,690 | Institution | 8.52% | 779,947,680 | |
| 9,523,986 | Institution | 7.73% | 707,536,920 | |
| 4,050,667 | Institution | 3.29% | 300,924,051 | |
| 3,839,464 | Institution | 3.12% | 285,233,781 | |
| 3,387,580 | Institution | 2.75% | 251,663,318 | |
| 3,202,390 | Institution | 2.60% | 237,905,553 | |
| 1,888,000 | Institution | 1.53% | 140,259,520 | |
| 1,648,428 | Institution | 1.34% | 122,461,716 | |
| 1,572,286 | Institution | 1.28% | 116,805,127 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,523,986 | Institution | 7.73% | 707,536,920 | |
| 4,050,667 | Institution | 3.29% | 300,924,051 | |
| 3,387,580 | Institution | 2.75% | 251,663,318 | |
| 3,202,390 | Institution | 2.60% | 237,905,553 | |
| 1,888,000 | Institution | 1.53% | 140,259,520 | |
| 1,572,286 | Institution | 1.28% | 116,805,127 | |
| 1,550,222 | Institution | 1.26% | 115,165,992 | |
| 1,528,900 | Institution | 1.24% | 113,581,981 | |
| 1,278,788 | Institution | 1.04% | 95,001,161 | |
| 1,178,780 | Institution | 0.96% | 87,571,566 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,131,513 | Institution | 3.32% | 306,930,101 | |
| 3,904,202 | Institution | 3.14% | 257,325,954 | |
| 2,843,447 | Institution | 2.29% | 187,411,592 | |
| 2,815,568 | Institution | 2.26% | 209,168,547 | |
| 1,591,392 | Institution | 1.28% | 104,888,647 | |
| 1,423,392 | Institution | 1.14% | 106,526,657 | |
| 1,366,547 | Institution | 1.10% | 90,069,113 | |
| 1,052,158 | Institution | 0.85% | 78,743,505 | |
| 927,372 | Institution | 0.75% | 68,894,466 | |
| 910,307 | Institution | 0.73% | 67,626,707 |
FAQ
Who Owns Cytokinetics (CYTK)?
According to the latest TipRanks data, approximately 2.73% of the company's stock is held by institutional investors, 0.83% is held by insiders, and 34.85% is held by retail investors.
What percentage of Cytokinetics (CYTK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.73% of Cytokinetics (CYTK) stock is held by institutional investors.
What percentage of Cytokinetics (CYTK) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.85% of Cytokinetics (CYTK) stock is held by retail investors.
Who owns the most shares of Cytokinetics (CYTK)?
Vanguard owns the most shares of Cytokinetics (CYTK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.